Overview

Safety and Efficacy of SRD441 Ointment in Patients With Atopic Dermatitis

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Atopic Dermatitis is a chronic inflammatory skin disease that affect 10 to 15% of children and 2 to 10% of adults. AD is characterised by an itchy skin eruption and may cover large parts of the body. The exact cause is unknown but is thought to be an interplay between genetic and and environmental factors. The objective of this study is to determine whether SRD441 ointment is a safe and effective therapy for mild to moderate Atopic Dermatitis.
Phase:
Phase 2
Details
Lead Sponsor:
Serentis Ltd.